<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="Francis pmcid: 7232887 doi: 10.1080/07391102.2020.17658761765876 : Research Article Repurposing of" exact="chloroquine" post="and some clinically approved antiviral drugs as effective therapeutics"/>
 <result pre="putative inhibitory potential of lopinavir, remdesivir, oseltamir, azithromycin, ribavirin, and" exact="chloroquine" post="towards V-ATPase, protein kinase A, SARS-CoV spike glycoprotein/ACE-2 complex"/>
 <result pre="His374, and His345 were predicted as the key residues for" exact="lopinavir" post="binding to human SARS-CoV spike glycoprotein/ACE-2 complex while His378,"/>
 <result pre="and Tyr510, Phe504, Met62, Tyr50, and His378 were predicted for" exact="azithromycin" post="as the key residues for binding to SARS-CoV spike"/>
 <result pre="SARS-CoV spike glycoprotein/ACE-2 complex. Moreover, it was also observed that" exact="chloroquine" post="has appreciable binding affinities for 3-Chymotrpsin- like protease and"/>
 <result pre="coronavirus. Communicated by Ramaswamy H. Sarma Keywords Coronavirus antiviral drugs" exact="chloroquine" post="Autodock tool pkCSM tool fig-count: table-count: page-count: word-count: 1."/>
 <result pre="selected clinically approved drugs (lopinavir, remdesivir, oseltamir, azithromycin, ribavirin, and" exact="chloroquine" post="recently discovered) as inhibitors of V-ATPase, protein kinase A,"/>
 <result pre="The toxicity risks of azithromycin, chloroquine, lopinavir, oseltamivir, remdesivir, and" exact="ribavirin" post="were predicted based on their ADMET profile. The ADMET"/>
 <result pre="The SDF structures of azithromycin, chloroquine, lopinavir, oseltamivir, remdesivir, and" exact="ribavirin" post="were retrieved from the PubChem database (www.pubchem.ncbi.nlm.nih.gov) (Kim et"/>
 <result pre="pharmacodynamics properties of the azithromycin, chloroquine, lopinavir, oseltamivir, remdesivir, and" exact="ribavirin" post="are presented in Tables 1â€“5. The prediction was carried"/>
 <result pre="1997; Hughes et al., 2008) (Table 1). However, a negative" exact="ribavirin" post="logP value means the ribavirinis a hydrophilic drug that"/>
 <result pre="also contribute to poor permeability, all the screened drugs except" exact="ribavirin" post="could be maintained in the system at appropriate concentrations."/>
 <result pre="their subcellular localization in the lysosome are remdesivir, azithromycin, and" exact="chloroquine" post="as predicted by ADMETSAR1 (Cheng et al., 2012). Lopinavir,"/>
 <result pre="by ADMETSAR1 (Cheng et al., 2012). Lopinavir, remdesivir, azithromycin, and" exact="chloroquine" post="were predicted to be substrates of P-glycoprotein, an efflux"/>
 <result pre="transporter found primarily in epithelial cells. However, lopinavir, remdesivir, and" exact="azithromycin" post="were also predicted as P-glycoprotein inhibitors. Thus, lopinavir, remdesivir,"/>
 <result pre="were also predicted as P-glycoprotein inhibitors. Thus, lopinavir, remdesivir, and" exact="azithromycin" post="could modulate the physiological functions of P-glycoprotein in limiting"/>
 <result pre="steady-state volume of distribution (VDss) showed that lopinavir, azithromycin, and" exact="ribavirin" post="had lower theoretical dose required for uniform distribution in"/>
 <result pre="for uniform distribution in the plasma than remdesivir, oseltamivir, and" exact="chloroquine" post="while the degree of diffusing across plasma membrane increases"/>
 <result pre="roles in drug metabolism is the CYP isozymes. Oseltamivir and" exact="ribavirin" post="showed low CYP promiscuity while lopinavir, remdesivir, azithromycin, and"/>
 <result pre="ribavirin showed low CYP promiscuity while lopinavir, remdesivir, azithromycin, and" exact="chloroquine" post="are substrates of CYP3A4 (Table 3). The lipophilicity of"/>
 <result pre="it inhibits CYP2C19, CYP2C9, CYP2D6, and CYP3A4. This shows that" exact="lopinavir" post="could be involved in drug-drug interaction (Cheng et al.,"/>
 <result pre="could initiate oxidative stress (Williams et al., 2004). Also, only" exact="chloroquine" post="was a substrate of renal organic cation transporter while"/>
 <result pre="through AMES toxicity testing showed that all the drugs except" exact="chloroquine" post="could be considered as non-mutagenic agents. However, the toxicities"/>
 <result pre="occur within a short period after administration. Lopinavir, remdesivir, and" exact="chloroquine" post="were also shown to have low toxic dose threshold"/>
 <result pre="induce hepatotoxicity (Table 5). Thus, administration of lopinavir, remdesivir, and" exact="chloroquine" post="could result in delayed ventricular repolarisation through inhibition of"/>
 <result pre="the work of Nukoolkarn et al. (2008), who reported that" exact="lopinavir" post="showed a high binding ability to the pocket site"/>
 <result pre="site of SAR-CoV. It was observed that lopinavir, remdesivir, and" exact="azithromycin" post="have the highest docking scores with the highest number"/>
 <result pre="with the highest number of hydrogen bonds formed respectively while" exact="ribavirin" post="has the least docking score with the least hydrogen"/>
 <result pre="and His345 were predicted to be the key residues for" exact="lopinavir" post="binding to human SARS-CoV spike glycoprotein/ACE-2 complex while His378,"/>
 <result pre="and Tyr510, Phe504, Met62, Tyr50, and His378 were predicted for" exact="azithromycin" post="as the key residues for binding to SARS-CoV spike"/>
 <result pre="responsible for the high binding score in lopinavir, remdesivir, and" exact="azithromycin" post="(Elokely &amp;amp; Doerksen, 2013). Moreover, it was also observed"/>
 <result pre="(Elokely &amp;amp; Doerksen, 2013). Moreover, it was also observed that" exact="chloroquine" post="which was recently found to be effective in the"/>
 <result pre="A when compared to Oseltamivir and ribavirin. This implies that" exact="chloroquine" post="could limit the proliferation of coronavirus by enhancing the"/>
 <result pre="and His378 were predicted to be the key residues for" exact="chloroquine" post="binding to human SARS-CoV spike glycoprotein/ACE-2 complex. Analysis of"/>
 <result pre="Analysis of the results of the autodock software revealed that" exact="chloroquine" post="has a considerable binding affinity with coronavirus target protease."/>
 <result pre="main protease. Out of the five already established antiviral drugs," exact="lopinavir" post="had the highest binding affinity towards SARS-CoV protease while"/>
 <result pre="lopinavir had the highest binding affinity towards SARS-CoV protease while" exact="ribavirin" post="had the lowest binding affinity. Chloroquine recently discovered for"/>
 <result pre="of coronavirus thereby preventing its cellular entry and proliferation. Although" exact="chloroquine" post="could bind to the selected target proteins/enzymes, the result"/>
 <result pre="(2020). Computational studies of drug repurposing and synergism of lopinavir," exact="oseltamivir" post="and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal"/>
 <result pre="studies of drug repurposing and synergism of lopinavir, oseltamivir and" exact="ritonavir" post="binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular"/>
 <result pre="MalaisreeM., AruksakulwongO., &amp;amp; HannongbuaS. (2008). Molecular dynamic simulations analysis of" exact="ritonavir" post="and lopinavir as SARS-CoV 3CL(pro) inhibitors. Journal of Theoretical"/>
 <result pre="&amp;amp; HannongbuaS. (2008). Molecular dynamic simulations analysis of ritonavir and" exact="lopinavir" post="as SARS-CoV 3CL(pro) inhibitors. Journal of Theoretical Biology, 254(4),"/>
</results>
